You are here: Industry Insights > Advaccine

News List

Great Market Potential: Important Nodes in the Domestic RSV Pharmaceutical Field Xiaoyaowan
December 14, 2023
Respiratory syncytial virus (RSV) is a common enveloped RNA virus that circulates in the winter and spring. It is mainly transmitted by direct contact with the nasal secretions and respiratory droplets of infected individuals.
INOVIO Expands Partnership with Advaccine to Conduct Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate americanpharmaceuticalreview
June 10, 2021
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced an expansion of its partnership with Advaccine ...
INOVIO, Advaccine Expand COVID Vax Alliance contractpharma
June 09, 2021
INOVIO has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co., Ltd. to jointly conduct a global Phase 3 segment of the ongoing Phase 2/3 trial called INNOVATE (INOVIO INO-4800 Vaccine Trial for Efficacy).
Inovio may move COVID-19 vaccine trial overseas after funding from US ends expresspharma
April 25, 2021
Inovio said, depending on the results of its mid-stage trial, it would run the late-stage study for its vaccine candidate, INO-4800, with partners such as China’s Advaccine and the International Vaccine Institute.
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact contractpharma
January 05, 2021
Partnership adds Asian manufacturing resource to INOVIO's global manufacturing consortium for INO-4800.